Virtu Financial LLC Makes New Investment in KORU Medical Systems, Inc. (NASDAQ:KRMD)

Virtu Financial LLC acquired a new stake in shares of KORU Medical Systems, Inc. (NASDAQ:KRMD) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 18,905 shares of the company’s stock, valued at approximately $73,000.

Several other institutional investors and hedge funds have also modified their holdings of KRMD. Connor Clark & Lunn Investment Management Ltd. lifted its stake in KORU Medical Systems by 77.7% in the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 61,412 shares of the company’s stock valued at $168,000 after buying an additional 26,860 shares in the last quarter. XTX Topco Ltd acquired a new stake in shares of KORU Medical Systems during the third quarter worth $34,000. Geode Capital Management LLC raised its holdings in shares of KORU Medical Systems by 6.5% during the third quarter. Geode Capital Management LLC now owns 462,128 shares of the company’s stock worth $1,262,000 after acquiring an additional 28,323 shares during the period. Empire Financial Management Company LLC bought a new stake in KORU Medical Systems in the 3rd quarter valued at $259,000. Finally, Calamos Advisors LLC acquired a new position in KORU Medical Systems in the 4th quarter worth $250,000. 58.60% of the stock is currently owned by institutional investors and hedge funds.

KORU Medical Systems Stock Down 1.9 %

NASDAQ:KRMD opened at $2.54 on Tuesday. KORU Medical Systems, Inc. has a twelve month low of $2.05 and a twelve month high of $5.05. The firm has a market capitalization of $116.73 million, a price-to-earnings ratio of -10.16 and a beta of 0.74. The company has a quick ratio of 2.37, a current ratio of 2.99 and a debt-to-equity ratio of 0.01. The stock’s 50 day moving average price is $3.67 and its two-hundred day moving average price is $3.43.

Analysts Set New Price Targets

A number of analysts have recently commented on the company. Piper Sandler restated a “neutral” rating and issued a $4.50 price target on shares of KORU Medical Systems in a report on Friday, February 14th. B. Riley upgraded KORU Medical Systems to a “strong-buy” rating in a research note on Thursday, March 13th. Lake Street Capital upped their price target on KORU Medical Systems from $4.00 to $5.00 and gave the stock a “buy” rating in a research report on Tuesday, January 14th. Finally, Craig Hallum lifted their price objective on shares of KORU Medical Systems from $5.00 to $6.00 and gave the company a “buy” rating in a report on Friday, January 17th. One investment analyst has rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, KORU Medical Systems has a consensus rating of “Buy” and an average target price of $4.70.

KORU Medical Systems Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.